Previous study has shown that glutamine analogs such as 6-diazo-5-oxo-L-norleucine (DON) and azaserine, the inhibitors of GFAT1, inhibited cancer cell growth [16], suggesting a potential role of GFAT in driving tumorigenesis. This evidence concerns the gene GFPT1 and cancer.